Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 92, Issue 1, 2011, Pages 82-91

  Bu, Liming ^a   Salto, Lorena M ^a   De Leon, Kevin J ^a   De Leon, Marino ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Fatty acid binding protein (FABP); Single nucleotide polymorphism (SNP); Type 2 diabetes mellitus (T2DM)

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FATTY ACID BINDING PROTEIN 1 GENE; FATTY ACID BINDING PROTEIN 2 GENE; FATTY ACID BINDING PROTEIN 3 GENE; FATTY ACID BINDING PROTEIN 4 GENE; FATTY ACID BINDING PROTEIN 5 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FATTY ACID-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79954613344     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.01.005     Document Type: Article

References (52)

1. Mitchell P., Gopinath B., McMahon C.M., Rochtchina E., Wang J.J., Boyages S.C., et al. Relationship of type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med 2009, 26:483-488.
2. Soria M.L., Sy R.G., Vega B.S., Ty-Willing T., Abenir-Gallardo A., Velandria F., et al. The incidence of type 2 diabetes mellitus in the Philippines: a 9-year cohort study. Diabetes Res Clin Pract 2009, 86:130-133.
3. Seifi S., Rahbar M., Lessan-Pezeshki M., Khatami M.R., Abbasi M.R., Mahdavi-Mazdeh M., et al. Posttransplant diabetes mellitus: incidence and risk factors. Transplant Proc 2009, 41:2811-2813.
4. Evertsen J., Alemzadeh R., Wang X. Increasing incidence of pediatric type 1 diabetes mellitus in Southeastern Wisconsin: relationship with body weight at diagnosis. PLoS One 2009, 4:e6873.
5. Clement K., Dina C., Basdevant A., Chastang N., Pelloux V., Lahlou N., et al. A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q. Diabetes 1999, 48:398-402.
6. Storch J., McDermott L. Structural and functional analysis of fatty acid-binding proteins. J Lipid Res 2009, 50(Suppl.):S126-S131.
7. Ebbesson S.O., Tejero M.E., Lopez-Alvarenga J.C., Harris W.S., Ebbesson L.O., Devereux R.B., et al. Individual saturated fatty acids are associated with different components of insulin resistance and glucose metabolism: the GOCADAN study. Int J Circumpolar Health 2010.
8. Bennaars-Eiden A., Higgins L., Hertzel A.V., Kapphahn R.J., Ferrington D.A., Bernlohr D.A. Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J Biol Chem 2002, 277:50693-50702.
9. Kucharekova M., Vissers W.H., Schalkwijk J.J., van de Kerkhof P.C., van der Valk P.G. Lack of upregulation of epidermal fatty acid binding protein in dithranol induced irritation. Eur J Dermatol 2003, 13:254-257.
10. Maeda K., Uysal K.T., Makowski L., Gorgun C.Z., Atsumi G., Parker R.A., et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 2003, 52:300-307.
11. Chan K.H., Song Y., Hsu Y.H., You N.C., L F.T., Liu S. Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the women's health initiative observational study. Obesity (Silver Spring) 2010.
12. Hoashi S., Hinenoya T., Tanaka A., Ohsaki H., Sasazaki S., Taniguchi M., et al. Association between fatty acid compositions and genotypes of FABP4 and LXR-alpha in Japanese black cattle. BMC Genet 2008, 9:84.
13. Cho S., Park T.S., Yoon D.H., Cheong H.S., Namgoong S., Park B.L., et al. Identification of genetic polymorphisms in FABP3 and FABP4 and putative association with back fat thickness in Korean native cattle. BMB Rep 2008, 41:29-34.
14. Coll B., Cabre A., Alonso-Villaverde C., Lazaro I., Aragones G., Parra S., et al. The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis 2008, 199:147-153.
15. Maclaren R., Cui W., Lu H., Simard S., Cianflone K. Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics 2010, 3:3.
16. Malhotra A., Wolford J.K. Analysis of quantitative lipid traits in the genetics of NIDDM (GENNID) study. Diabetes 2005, 54:3007-3014.
17. Raffel L.J., Robbins D.C., Norris J.M., Boerwinkle E., DeFronzo R.A., Elbein S.C., et al. The GENNID study. A resource for mapping the genes that cause NIDDM. Diabetes Care 1996, 19:864-872.
18. Fisher E., Weikert C., Klapper M., Lindner I., Mohlig M., Spranger J., et al. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol Genet Metab 2007, 91:278-284.
19. Pratley R.E., Baier L., Pan D.A., Salbe A.D., Storlien L., Ravussin E., et al. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 2000, 41:2002-2008.
20. Shin H.D., Kim L.H., Park B.L., Jung H.S., Cho Y.M., Moon M.K., et al. Polymorphisms in fatty acid-binding protein-3 (FABP3) - putative association with type 2 diabetes mellitus. Hum Mutat 2003, 22:180.
21. Tuncman G., Erbay E., Hom X., De Vivo I., Campos H., Rimm E.B., et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A 2006, 103:6970-6975.
22. Hamajima N., Saito T., Matsuo K., Kozaki K., Takahashi T., Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000, 91:865-868.
23. Skol A.D., Scott L.J., Abecasis G.R., Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213.
24. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
25. Ardlie K.G., Kruglyak L., Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002, 3:299-309.
26. Formanack M.L., Baier L.J. Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia 2004, 47:349-351.
27. de Luis D.A., Aller R., Izaola O., Sagrado M.G., Conde R. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: a randomized clinical trial. Diabetes Res Clin Pract 2008, 82:113-118.
28. De Leon M., Welcher A.A., Nahin R.H., Liu Y., Ruda M.A., Shooter E.M., et al. Fatty acid binding protein is induced in neurons of the dorsal root ganglia after peripheral nerve injury. J Neurosci Res 1996, 44:283-292.
29. Biron-Shental T., Schaiff W.T., Ratajczak C.K., Bildirici I., Nelson D.M., Sadovsky Y. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol 2007, 197:516. e511-6.
30. Storch J., Thumser A.E. Tissue-specific functions in the FABP (fatty acid-binding protein) family. J Biol Chem 2010.
31. Bohme M., Nitz I., Doring F., Klapper M. Analysis of the transcriptional regulation of the FABP2 promoter haplotypes by PPARgamma/RXRalpha and Oct-1. Biochim Biophys Acta 2008, 1779:616-621.
32. Li Y., Fisher E., Klapper M., Boeing H., Pfeiffer A., Hampe J., et al. Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm Metab Res 2006, 38:300-307.
33. Watanabe R., Fujii H., Odani S., Sakakibara J., Yamamoto A., Ito M., et al. Molecular cloning of a cDNA encoding a novel fatty acid-binding protein from rat skin. Biochem Biophys Res Commun 1994, 200:253-259.
34. Liu J.W., Almaguel F.G., Bu L., De Leon D.D., De Leon M. Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids. J Neurochem 2008, 106:2015-2029.
35. Liu Y., Longo L.D., De Leon M. In situ and immunocytochemical localization of E-FABP mRNA and protein during neuronal migration and differentiation in the rat brain. Brain Res 2000, 852:16-27.
36. Liu Y., Molina C.A., Welcher A.A., Longo L.D., De Leon M. Expression of DA11, a neuronal-injury-induced fatty acid binding protein, coincides with axon growth and neuronal differentiation during central nervous system development. J Neurosci Res 1997, 48:551-562.
37. Hoekstra M., Stitzinger M., van Wanrooij E.J., Michon I.N., Kruijt J.K., Kamphorst J., et al. Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. J Lipid Res 2006, 47:2198-2207.
38. van der Horst D.J., van Doorn J.M., Passier P.C., Vork M.M., Glatz J.F. Role of fatty acid-binding protein in lipid metabolism of insect flight muscle. Mol Cell Biochem 1993, 123:145-152.
39. Li Z., Huang C., Bai S., Pan X., Zhou R., Wei Y., et al. Prognostic evaluation of epidermal fatty acid-binding protein and calcyphosine, two proteins implicated in endometrial cancer using a proteomic approach. Int J Cancer 2008, 123:2377-2383.
40. Yamamoto N., Kaneko I., Motohashi K., Sakagami H., Adachi Y., Tokuda N., et al. Fatty acid-binding protein regulates LPS-induced TNF-alpha production in mast cells. Prostaglandins Leukot Essent Fatty Acids 2008, 79:21-26.
41. Yeung D.C., Xu A., Tso A.W., Chow W.S., Wat N.M., Fong C.H., et al. Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabetes Care 2009, 32:132-134.
42. Westerbacka J., Kolak M., Kiviluoto T., Arkkila P., Siren J., Hamsten A., et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007, 56:2759-2765.
43. Maeda K., Cao H., Kono K., Gorgun C.Z., Furuhashi M., Uysal K.T., et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 2005, 1:107-119.
44. Silver K. Identities and locations of 12 uranium mills in 1959 Atomic Energy Commission report. Arch Environ Health 2000, 55:361-362.
45. Weiss E.P., Brown M.D., Shuldiner A.R., Hagberg J.M. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects. Physiol Genomics 2002, 10:145-157.
46. Lei H.H., Coresh J., Shuldiner A.R., Boerwinkle E., Brancati F.L. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 1999, 48:1868-1872.
47. Tavridou A., Arvanitidis K.I., Tiptiri-Kourpeti A., Petridis I., Ragia G., Kyroglou S., et al. Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population. Diabetes Res Clin Pract 2009, 84:132-137.
48. Fisher E., Li Y., Burwinkel B., Kuhr V., Hoffmann K., Mohlig M., et al. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm Metab Res 2006, 38:341-345.
49. Albala C., Villarroel A., Santos J.L., Angel B., Lera L., Liberman C., et al. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res Clin Pract 2007, 77:245-250.
50. Perez-Bravo F., Fuentes M., Angel B., Sanchez H., Carrasco E., Santos J.L., et al. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile. Acta Diabetol 2006, 43:93-98.
51. Yamada Y., Kato K., Oguri M., Yoshida T., Yokoi K., Watanabe S., et al. Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int J Mol Med 2008, 21:801-808.
52. Shearer J., Fueger P.T., Bracy D.P., Wasserman D.H., Rottman J.N. Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Diabetes 2005, 54:3133-3139.